🔗 tinyurl.com/mphva443
🔗 tinyurl.com/mphva443
#ASCT #Lymphoma #MATRix #Chemotherapy
substack.com/@garlandcoac...
#ASCT #Lymphoma #MATRix #Chemotherapy
substack.com/@garlandcoac...
🎤 Eichenauer: stage-adapted NLPHL treatment.
💬 Zilioli: in older cHL, fitness assessment is key.
🎙️Crump: BrECADD and nivo-AVD are new standards in advanced cHL.
🔊André: at relapse, novel agents, but salvage + ASCT remains.
#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm
🎤 Eichenauer: stage-adapted NLPHL treatment.
💬 Zilioli: in older cHL, fitness assessment is key.
🎙️Crump: BrECADD and nivo-AVD are new standards in advanced cHL.
🔊André: at relapse, novel agents, but salvage + ASCT remains.
#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm
#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
Nerdaiada #bskytes, bora espalhar a palavra da Divulgação Científica?
✨FUTURAS CIENTISTAS 2027 - inscrições prorrogadas até 06/11/2026!
🌐 www.futurascientistas.com.br
👩🏽🎓Estudantes do 2º ano EM da rede pública estadual
👩🏫Professoras da rede pública estadual
💰Bolsa R$300
Nerdaiada #bskytes, bora espalhar a palavra da Divulgação Científica?
✨FUTURAS CIENTISTAS 2027 - inscrições prorrogadas até 06/11/2026!
🌐 www.futurascientistas.com.br
👩🏽🎓Estudantes do 2º ano EM da rede pública estadual
👩🏫Professoras da rede pública estadual
💰Bolsa R$300
💬 Laurence de Leval on diagnosing nodal T-cell lymphoma entities 🧵
🗣️ Alison Moskowitz: BV-CH(E)P → ASCT still standard for CD30+ PTCL; the future is subtype-driven.
#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
💬 Laurence de Leval on diagnosing nodal T-cell lymphoma entities 🧵
🗣️ Alison Moskowitz: BV-CH(E)P → ASCT still standard for CD30+ PTCL; the future is subtype-driven.
#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
Read more: www.onclive.com/view/ixotatu...
@myesmo.bsky.social #ESMO26 @mskcancercenter.bsky.social
Read more: www.onclive.com/view/ixotatu...
@myesmo.bsky.social #ESMO26 @mskcancercenter.bsky.social
🔗 tinyurl.com/mw7j4jdb
🔗 tinyurl.com/mw7j4jdb
I was so uninspired this month, but that changes today!
I was so uninspired this month, but that changes today!
- 39 pts; 41% 1° refractory
- ORR 100% (CR 95%)
- 95% proceeded to ASCT
- 5-yr PFS 91%, OS 94% (!!!)
Long-term remissions/cures with CPI + ASCT in R/R cHL. Interesting question remains re: 2nd-line regimens with use of frontline CPI. #lymsm
- 39 pts; 41% 1° refractory
- ORR 100% (CR 95%)
- 95% proceeded to ASCT
- 5-yr PFS 91%, OS 94% (!!!)
Long-term remissions/cures with CPI + ASCT in R/R cHL. Interesting question remains re: 2nd-line regimens with use of frontline CPI. #lymsm
otherrole.substack.com/p/stem-cell-...
#ASCT #Lymphoma #Collection
otherrole.substack.com/p/stem-cell-...
#ASCT #Lymphoma #Collection
Scott V2.0 has arrived 🥂🍾
#ASCT #TransplantDone #Lymphoma #MS
Scott V2.0 has arrived 🥂🍾
#ASCT #TransplantDone #Lymphoma #MS
Yang Li et al.
#arXiv #cs.AI
My neutrophils are zero & will be for a few days.
Stem Cells can only do good now.
The only way is up.
#ASCT #Lymphoma #MS #StemCellTransplant
My neutrophils are zero & will be for a few days.
Stem Cells can only do good now.
The only way is up.
#ASCT #Lymphoma #MS #StemCellTransplant
Wir entwickeln in einem neuen BMFTR-Projekt mit 30 Partnern Lösungen, um autonome Shuttles sicher in den ÖPNV zu integrieren. Mithilfe digitaler Zwillinge und Crowd-Sensing werden Straßenraumdaten kontinuierlich aktualisiert: 👉 www.fokus.fraunhofer.de/de/asct/news...
Wir entwickeln in einem neuen BMFTR-Projekt mit 30 Partnern Lösungen, um autonome Shuttles sicher in den ÖPNV zu integrieren. Mithilfe digitaler Zwillinge und Crowd-Sensing werden Straßenraumdaten kontinuierlich aktualisiert: 👉 www.fokus.fraunhofer.de/de/asct/news...